Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus [RETIRED]. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.
Silberstein
S D
SD
Comprehensive Headache Center, Philadelphia, PA 19144.
Young
W B
WB
D004087:Dihydroergotamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D004878:Ergotamine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*
D004087:Dihydroergotamine; D004878:Ergotamine